Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy

Clinical trial NCT03742193 · UNKNOWN

Trial details

NCT number: NCT03742193
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Pulmonary Metastases Apatinib

Start date: 2019-08-11
Primary completion: 2023-11-15
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.